Optimization of VSV‐ΔG‐spike production process with the Ambr15 system for a SARS‐COV‐2 vaccine

To face the coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus, our institute has developed the rVSV‐ΔG‐spike vaccine, in which the glycoprotein of vesicular stomatitis virus (VSV) was replaced by the spike protein of SARS‐CoV‐2. Many p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Osnat, Jayson, Avital, Goldvaser, Michael, Dor, Eyal, Monash, Arik, Levin, Lilach, Cherry, Lilach, Lupu, Edith, Natan, Niva, Girshengorn, Meni, Epstein, Eyal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082513/
https://www.ncbi.nlm.nih.gov/pubmed/35319097
http://dx.doi.org/10.1002/bit.28088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082513/
https://www.ncbi.nlm.nih.gov/pubmed/35319097
http://dx.doi.org/10.1002/bit.28088

Ejemplares similares